SEPCX | TRNEX | SEPCX / TRNEX | |
Total Expense Ratio | 4.85 | 0.57 | 851% |
Annual Report Gross Expense Ratio | 4.85 | 0.57 | 851% |
Fund Existence | 22 years | 9 years | - |
Gain YTD | -1.390 | 2.964 | -47% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 500000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.01M | 2.32B | 0% |
Annual Yield % from dividends | 1.60 | 2.27 | 71% |
Returns for 1 year | -11.99 | -3.63 | 331% |
Returns for 3 years | -10.43 | -5.37 | 194% |
Returns for 5 years | 55.21 | 53.70 | 103% |
Returns for 10 years | -14.15 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
QASGX | 25.25 | 0.39 | +1.57% |
Federated Hermes MDT Small Cap Growth A | |||
JFNSX | 61.87 | 0.21 | +0.34% |
Janus Henderson Global Life Sciences S | |||
JEMZX | 9.51 | N/A | N/A |
JHancock Emerging Markets Equity C | |||
EEMHX | 8.60 | N/A | N/A |
MFS Emerging Markets Equity Research R6 | |||
TMCAX | 11.53 | N/A | N/A |
RBC SMID Cap Growth A |